Skip to main content
. Author manuscript; available in PMC: 2017 Feb 5.
Published in final edited form as: Chem Res Toxicol. 2016 Jul 5;29(12):1903–1911. doi: 10.1021/acs.chemrestox.6b00136

Figure 1.

Figure 1

Metabolic pathways of thalidomide (A) and 5-n-butyl-pyrazolo[1,5-a]pyrimidine (B). Proposed formation of the glutathione conjugate (A) is modified from Chowdhury et al.43. Proposed mechanism for a putative quinone imine metabolite and conjugate formation at the 6-position (B) is taken from Kuribayashi et al.50